Immunic Inc.

09/03/2024 | Press release | Distributed by Public on 09/03/2024 06:31

Material Agreement Form 8 K

Item 1.01. Entry into a Material Definitive Agreement.

On August 29, 2024, Immunic, Inc. (the "Company") and Dr. Duane Nash entered into Addendum Number 6 (the "Addendum") to the Employment Agreement dated April 17, 2020, as amended as of October 15, 2020, April 15, 2021, March 15, 2022, December 28, 2022 and October 17, 2023, to extend the term of Dr. Nash's employment as Executive Chairman of the Board of Directors of the Company (the "Board") to December 31, 2025.

In connection with the Addendum, the Company increased Dr. Nash's monthly base salary to $33,987 from $32,368 (which includes the cash retainer payable for serving on the Company's Board or for acting as the Chairman of the Board).

The Addendum is attached as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.